Progress of autologous hematopoietic stem cell transplantation for malignant lymphoma treatment

Autologous hematopoietic stem cell transplantation (AHSCT) is an important method for treatment of malignant lymphoma. Its treatment process is relatively complex, and the curative effect can be affected by many factors. AHSCT has been widely applied in different subtypes of ML treatment, and looking for effective prognostic factors to further differentiate patients who may benefit from AHSCT and formulating reasonable transplantation are important issues for the clinical doctors to deal with. This article briefly reviews the clinical progress of AHSCT for ML treatment. Key words: Lymphoma; Hematopoietic stem cell transplantation; Prognosis